Evidence map›Paper›PMID 33868624›Full record

ArticleTherapeutic advances in chronic disease2021

Benefit of a pharmacist-led intervention for medication management of renal transplant patients: a controlled before-and-after study.

Jeremy Chambord, Lionel Couzi, Pierre Merville, Karine Moreau, Fabien Xuereb, Sarah Djabarouti

Open access · goldAbstract read
In one paragraph

Article in Therapeutic advances in chronic disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. The expanded role of the transplant pharmacist: A 10-year follow-up.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jeremy ChambordClinical Pharmacy, Bordeaux Hospital University, France.ORCID https://orcid.org/0000-0001-8729-3907
Lionel CouziDepartment of Nephrology and Renal Transplantation, CHU Bordeaux, Bordeaux, Aquitaine, France.
Pierre MervilleDepartment of Nephrology and Renal Transplantation, CHU Bordeaux, Bordeaux, Aquitaine, France.
Karine MoreauDepartment of Nephrology and Renal Transplantation, CHU Bordeaux, Bordeaux, Aquitaine, France.
Fabien XuerebCHU Bordeaux, Pharmacy, Bordeaux, Pessac, France Univ. Bordeaux, INSERM U1034, Bordeaux, France.
Sarah DjabaroutiCHU Bordeaux, Pharmacy, Bordeaux, Pessac, France Univ. Bordeaux, INSERM U1034, Bordeaux, France.
Centre Hospitalier Universitaire de Bordeaux · FRCentre National de la Recherche Scientifique · FRUniversité de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo assess the effect of a pharmacist-led intervention, using Barrows cards method, during the first year after renal transplantation, on patient knowledge about their treatment, medication adherence and exposure to treatment in a French cohort.

methodsWe conducted a before-and-after comparative study between two groups of patients: those who benefited from a complementary pharmacist-led intervention [intervention group (IG),

resultsAt visit 2, IG patients achieved a significantly higher knowledge score than CG patients (83.3%

conclusionsOur intervention showed a positive effect on patient knowledge about their treatment. However, our results did not show any improvement in overall medication adherence, which was likely to be because of the initially high level of adherence in our study population. Nevertheless, the intervention appears to have improved adherence in non-adherent patients with low knowledge scores.

Indexed as

adherenceBarrows cardsknowledge improvementpharmacist-led interventionRenal transplantation

Identifiers

PMID33868624
PMCPMC8024450
OpenAlexW3142121725

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.